Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.14%
1,102.18
+1.57
+0.14%
1,100.611,106.151,114.281,098.89
SIXC
Communications
SIXC
Communications
SIXC
+0.64%
616.24
+3.94
+0.64%
612.30612.30616.40612.30
SIXE
Energy
SIXE
Energy
SIXE
+1.21%
1,189.72
+14.26
+1.21%
1,175.461,182.971,193.951,182.97
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,725.69
-3.43
-0.20%
1,729.121,731.371,754.071,718.58
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
643.62
-1.11
-0.17%
644.73645.31649.16642.15
SIXR
Staples
SIXR
Staples
SIXR
+0.33%
829.79
+2.70
+0.33%
827.09828.05833.90827.27
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.66%
213.40
-1.42
-0.66%
214.82214.82216.61212.62
SIXT
Technology
SIXT
Technology
SIXT
+2.27%
3,185.92
+70.75
+2.27%
3,115.173,142.773,186.203,133.07
SIXU
Utilities
SIXU
Utilities
SIXU
-0.16%
908.94
-1.49
-0.16%
910.43915.18923.94906.03
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,478.96
+4.46
+0.30%
1,474.501,480.841,491.461,475.55
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.02%
2,405.36
-0.51
-0.02%
2,405.872,415.572,420.792,398.99
PACB:NASDAQ
Pacific Biosciences of California Inc
$1.71
-1.16%
(-0.020) 1D
$1.68
-1.75% (-0.030)
Pre-market
Closed: Apr 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PACB...
Open
$1.76
High
$1.77
Low
$1.67
Mkt. cap
516.42M
Avg. vol.
5.65M
Volume
507.00
52-wk high
$2.73
52-wk low
$0.85
EPS
-$1.82
Beta
2.33
Shares outstanding
302.00M
No. of employees
485
News stories
From sources across the web
Profile
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
About Pacific Biosciences of California Inc
CEOChristian Henry
Employees485
Founded2004
HeadquartersMenlo Park, California, United States
SectorHealth care
Websitepacb.com
Last report
Feb 12, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-0.12/ (-0.13 est.)USD
+10.77%beat
Revenue / Estimate
44.64M/ (42.79M est.)USD
+4.34%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
37.15M
39.77M
38.44M
44.64M
Cost of goods sold
30.11M
24.88M
22.28M
40.28M
Cost of revenue
30.11M
24.88M
22.28M
40.28M
Research and development expenses
29.05M
22.53M
22.85M
23.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.17M
36.18M
31.10M
35.75M
Operating expense
439.68M
59.72M
54.96M
64.42M
Total operating expenses
469.79M
84.60M
77.24M
104.71M
Operating income
-432.63M
-44.83M
-38.80M
-60.06M
Other non operating income
2.59M
4.67M
2.92M
6.48M
EBT including unusual items
-426.38M
-41.90M
-37.62M
-40.17M
EBT excluding unusual items
-431.78M
-41.90M
-37.62M
-55.33M
Income tax expense
-302.00K
35.00K
383.00K
202.00K
Effective tax rate
0.07%
-0.08%
-1.02%
-0.50%
Other operating expenses
4.07M
-
-
4.18M
Net income
-426.08M
-41.93M
-38.00M
-40.37M
Net profit margin
-1,146.81%
-105.44%
-98.85%
-90.43%
Earnings per share
-0.15
-0.13
-0.12
-0.12
Interest and investment income
-
-
-
-
Interest expense
-1.74M
-1.74M
-1.74M
-1.74M
Net interest expenses
-1.74M
-1.74M
-1.74M
-1.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
-61.11M
-41.15M
-35.32M
-56.31M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more